Focus Partners Wealth

Position in JNJ — Johnson & Johnson

CIK 1542153 ST LOUIS, MO

Position in JNJ

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$377,980,757

-$13,923,784 QoQ

Shares Held

1,488,289

-7.2% QoQ

Ownership

0.062%

of shares outstanding

% of Portfolio

0.74%

of 13F equity value

Holder Rank

#126

of 4,676 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 50% Shared 0% None 50%

Healthcare · as of Jun 30, 2026

Focus Partners Wealth holds $1,442,065,327 across 15 Drug Manufacturers - General names. JNJ ranks #1 (26.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	1,488,289	$377,980,757
2	LLY	ELI LILLY & Co	260,045	$311,905,800
3	ABBV	AbbVie Inc.	929,566	$233,915,988
4	MRK	Merck & Co., Inc.	1,375,512	$176,753,292
5	AMGN	Amgen Inc	315,585	$114,279,640
6	PFE	Pfizer Inc	2,693,994	$64,871,375
7	GILD	Gilead Sciences, Inc.	475,579	$60,084,650
8	NVS	Novartis AG	235,657	$36,932,165

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$377,980,757	1,488,289	-7.2%	Shares	Sole	2026-08-12
2026-03-31	$391,904,541	1,603,275	+0.3%	Shares	Sole	2026-05-15
2025-12-31	$330,900,219	1,598,938	+23.5%	Shares	Sole	2026-02-13
2025-09-30	$240,112,224	1,294,964	+3.0%	Shares	Sole	2025-11-14
2025-06-30	$192,049,825	1,257,282	+5.4%	Shares	Sole	2025-08-14
2025-03-31	$197,909,807	1,193,378	+15.4%	Shares	Sole	2025-05-20
2024-12-31	$149,531,150	1,033,959	+15.6%	Shares	Sole	2025-05-20
2024-09-30	$144,956,025	894,459	-43.4%	Shares	Sole	2024-11-14
2024-06-30	$231,098,836	1,581,136	+261.3%	Shares	Sole	2024-08-15
2024-03-31	$69,222,520	437,591	+142.0%	Shares	Sole	2024-05-16
2023-12-31	$28,345,331	180,843	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.